Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis.

Seo SK, Park HY, Choi JH, Kim WY, Kim YH, Jung HW, Kwon B, Lee HW, Kwon BS.

J Immunol. 2003 Jul 15;171(2):576-83.

4.

Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes.

Nam KO, Kang H, Shin SM, Cho KH, Kwon B, Kwon BS, Kim SJ, Lee HW.

J Immunol. 2005 Feb 15;174(4):1898-905.

5.

Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.

Futagawa T, Akiba H, Kodama T, Takeda K, Hosoda Y, Yagita H, Okumura K.

Int Immunol. 2002 Mar;14(3):275-86.

PMID:
11867564
6.

Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Kwon BS, Panoskaltsis-Mortari A, Kwak KB, Peschon JJ, Taylor PA.

J Immunol. 2001 Mar 1;166(5):3174-83.

7.
8.

Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB.

Loo DT, Chalupny NJ, Bajorath J, Shuford WW, Mittler RS, Aruffo A.

J Biol Chem. 1997 Mar 7;272(10):6448-56.

9.

During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.

Hendriks J, Xiao Y, Rossen JW, van der Sluijs KF, Sugamura K, Ishii N, Borst J.

J Immunol. 2005 Aug 1;175(3):1665-76.

10.

4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae.

Wu ZQ, Khan AQ, Shen Y, Wolcott KM, Dawicki W, Watts TH, Mittler RS, Snapper CM.

Infect Immun. 2003 Jan;71(1):196-204.

11.

Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.

Cho HR, Kwon B, Yagita H, La S, Lee EA, Kim JE, Akiba H, Kim J, Suh JH, Vinay DS, Ju SA, Kim BS, Mittler RS, Okumura K, Kwon BS.

Transpl Int. 2004 Aug;17(7):351-61. Epub 2004 Jul 31.

12.
13.

4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.

Dawicki W, Bertram EM, Sharpe AH, Watts TH.

J Immunol. 2004 Nov 15;173(10):5944-51.

14.

CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.

Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT.

J Immunol. 2004 Jan 15;172(2):1237-45.

15.
16.

IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.

Pulle G, Vidric M, Watts TH.

J Immunol. 2006 Mar 1;176(5):2739-48.

17.

[Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis].

Xia LK, Zhang JS, Chen XL, Wang AY.

Zhonghua Yan Ke Za Zhi. 2005 May;41(5):403-8. Chinese.

PMID:
15938803
18.

Immunotherapy targeting 4-1BB and its ligand.

Vinay DS, Kwon BS.

Int J Hematol. 2006 Jan;83(1):23-8.

PMID:
16443548
19.

Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.

Xia L, Zhang S, Cao Z, Hu Y, Yang H, Wang D.

Microbes Infect. 2013 Feb;15(2):126-39. doi: 10.1016/j.micinf.2012.10.017. Epub 2012 Nov 14.

PMID:
23159245
20.

4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.

Lee HW, Park SJ, Choi BK, Kim HH, Nam KO, Kwon BS.

J Immunol. 2002 Nov 1;169(9):4882-8.

Supplemental Content

Support Center